Nantahala Capital Management - Q2 2016 holdings

$922 Million is the total value of Nantahala Capital Management's 73 reported holdings in Q2 2016. The portfolio turnover from Q1 2016 to Q2 2016 was 32.4% .

 Value Shares↓ Weighting
IWM SellISHARES TRput$197,766,000
-16.5%
1,720,000
-19.6%
21.44%
-12.0%
DRII SellDIAMOND RESORTS INTL INC$50,917,000
+13.4%
1,699,487
-8.0%
5.52%
+19.5%
SGMS  SCIENTIFIC GAMES CORPcall$42,257,000
-2.5%
4,598,2000.0%4.58%
+2.7%
DRII  DIAMOND RESORTS INTL INCcall$41,944,000
+23.3%
1,400,0000.0%4.55%
+29.9%
FCFS BuyFIRST CASH FINL SVCS INC$40,400,000
+79.1%
787,073
+60.7%
4.38%
+88.8%
YHOO SellYAHOO INC$39,167,000
-1.1%
1,042,776
-3.1%
4.25%
+4.2%
DLB SellDOLBY LABORATORIES INC$39,060,000
+7.0%
816,307
-2.8%
4.23%
+12.8%
SODA SellSODASTREAM INTERNATIONAL LTD$29,570,000
+48.9%
1,386,290
-1.7%
3.21%
+56.9%
SGMS SellSCIENTIFIC GAMES CORPcl a$27,267,000
-19.4%
2,967,002
-17.3%
2.96%
-15.0%
QQQ NewPOWERSHARES QQQ TRUSTput$26,885,000250,000
+100.0%
2.92%
CASH BuyMETA FINL GROUP INC$24,160,000
+12.4%
474,098
+0.6%
2.62%
+18.5%
SCLN SellSCICLONE PHARMACEUTICALS INC$23,110,000
+3.7%
1,769,558
-12.6%
2.50%
+9.3%
CDXS BuyCODEXIS INC$22,349,000
+43.3%
5,545,543
+10.6%
2.42%
+51.1%
CTRN BuyCITI TRENDS INC$18,609,000
+4.1%
1,198,280
+19.5%
2.02%
+9.7%
ARQL BuyARQULE INC$17,032,000
+24.6%
8,964,045
+4.9%
1.85%
+31.3%
ORM SellOWENS RLTY MTG INC$15,247,000
+1.1%
916,268
-2.9%
1.65%
+6.6%
IWM SellISHARES TRcall$13,798,000
-69.6%
120,000
-70.8%
1.50%
-68.0%
BPI SellBRIDGEPOINT ED INC$13,730,000
-38.1%
1,896,445
-13.9%
1.49%
-34.8%
LXFR BuyLUXFER HLDGS PLCsponsored adr$12,866,000
+53.3%
1,069,501
+35.2%
1.40%
+61.5%
CROX SellCROCS INC$12,614,000
-15.7%
1,118,223
-28.1%
1.37%
-11.2%
AKBA BuyAKEBIA THERAPEUTICS INC$12,569,000
+3.5%
1,680,390
+24.7%
1.36%
+9.1%
PTIE SellPAIN THERAPEUTICS INC$12,560,000
-12.5%
5,735,324
-10.9%
1.36%
-7.7%
GDEN BuyGOLDEN ENTMT INC$11,597,000
+15.0%
992,068
+6.7%
1.26%
+21.2%
SellIMPERIAL HLDGS INCnote 8.500% 2/1$10,723,000
-14.0%
11,970,000
-14.3%
1.16%
-9.4%
EZPW BuyEZCORP INCcl a non vtg$10,638,000
+535.1%
1,407,086
+149.6%
1.15%
+570.3%
QADA BuyQAD INCcl a$9,996,000
-2.9%
518,716
+7.0%
1.08%
+2.4%
TBBK  BANCORP INC DEL$9,185,000
+5.2%
1,525,7870.0%1.00%
+10.9%
PIP BuyPHARMATHENE INC$7,935,000
+24.2%
3,252,045
+0.0%
0.86%
+30.9%
RH NewRESTORATION HARDWARE HLDGS I$7,826,000272,876
+100.0%
0.85%
SFR BuyCOLONY STARWOOD HOMES$7,786,000
+36.8%
255,951
+11.3%
0.84%
+44.3%
RACE SellFERRARI N V$7,760,000
-13.5%
189,582
-11.9%
0.84%
-8.9%
RLGT SellRADIANT LOGISTICS INC$7,652,000
-22.0%
2,550,665
-7.2%
0.83%
-17.7%
TWMC SellTRANS WORLD ENTMT CORP$6,690,000
-12.4%
1,784,034
-12.3%
0.72%
-7.8%
CRMT NewAMERICAS CAR MART INC$6,443,000228,156
+100.0%
0.70%
EMGCQ SellEMERGENT CAP INC$6,201,000
-20.4%
1,845,659
-4.7%
0.67%
-16.1%
FCAU SellFIAT CHRYSLER AUTOMOBILES Ncall$6,094,000
-24.4%
995,800
-0.4%
0.66%
-20.3%
RBCAA SellREPUBLIC BANCORP KYcl a$5,286,000
-3.3%
191,314
-9.6%
0.57%
+2.0%
M SellMACYS INC$5,042,000
-64.2%
150,000
-53.0%
0.55%
-62.2%
EPM SellEVOLUTION PETROLEUM CORP$4,941,000
-1.9%
903,282
-12.9%
0.54%
+3.5%
NewEZCORP INCnote 2.625% 6/1$4,622,0005,500,000
+100.0%
0.50%
QADB  QAD INCcl b$4,252,000
-2.4%
245,7650.0%0.46%
+2.9%
FNTC NewFINTECH ACQUISITION CORP$3,974,000397,363
+100.0%
0.43%
ESINQ SellITT EDUCATIONAL SERVICES INC$3,962,000
-54.5%
2,063,792
-26.8%
0.43%
-52.0%
FALC SellFALCONSTOR SOFTWARE INC$3,563,000
-37.4%
3,393,018
-20.2%
0.39%
-34.1%
FCAU SellFIAT CHRYSLER AUTOMOBILES N$3,329,000
-29.8%
543,952
-7.5%
0.36%
-26.0%
LINC BuyLINCOLN EDL SVCS CORP$3,301,000
-38.1%
2,200,494
+2.3%
0.36%
-34.8%
ONDK NewON DECK CAP INC$3,051,000592,515
+100.0%
0.33%
CGNT BuyCOGENTIX MED INC$3,016,000
+10.1%
3,134,956
+25.8%
0.33%
+16.0%
SRPT SellSAREPTA THERAPEUTICS INCcall$2,861,000
-26.7%
150,000
-25.0%
0.31%
-22.9%
SXC SellSUNCOKE ENERGY INC$2,702,000
-52.5%
464,182
-47.0%
0.29%
-50.0%
DVD SellDOVER MOTORSPORTS INC$2,598,000
-8.4%
1,197,313
-4.1%
0.28%
-3.4%
RM SellREGIONAL MGMT CORP$2,536,000
-74.3%
172,974
-70.0%
0.28%
-72.9%
CSH SellCASH AMER INTL INC$2,063,000
-76.6%
48,394
-78.8%
0.22%
-75.3%
CCXI NewCHEMOCENTRYX INC$1,925,000428,687
+100.0%
0.21%
ESINQ NewITT EDUCATIONAL SERVICES INCcall$1,920,0001,000,000
+100.0%
0.21%
TA NewTRAVELCENTERS AMER LLC$1,244,000152,511
+100.0%
0.14%
DDE BuyDOVER DOWNS GAMING & ENTMT I$1,136,000
+465.2%
1,071,772
+470.2%
0.12%
+485.7%
SXCP SellSUNCOKE ENERGY PARTNERS L P$1,052,000
-24.0%
97,375
-48.0%
0.11%
-19.7%
EMMS BuyEMMIS COMMUNICATIONS CORPcl a$996,000
+38.3%
1,368,777
+10.6%
0.11%
+45.9%
MFCB SellMFC BANCORP LTD$740,000
-3.6%
337,978
-12.9%
0.08%
+1.3%
WHF SellWHITEHORSE FIN INC$618,000
-74.7%
57,132
-75.8%
0.07%
-73.4%
PHMD  PHOTOMEDEX INC$349,000
-53.3%
1,384,7770.0%0.04%
-50.6%
FNTCW NewFINTECH ACQUISITION CORP*w exp 02/19/202$318,000397,363
+100.0%
0.03%
OCN  OCWEN FINL CORPcall$318,000
-30.7%
186,0000.0%0.03%
-27.7%
CASLQ  CASTLE A M & CO$221,000
-39.3%
134,7640.0%0.02%
-35.1%
UTI SellUNIVERSAL TECHNICAL INST INC$111,000
-87.2%
49,003
-75.6%
0.01%
-86.5%
CVO ExitCENVEO INC$0-1,247,162
-100.0%
-0.06%
SGYPQ ExitSYNERGY PHARMACEUTICALS DEL$0-300,000
-100.0%
-0.08%
GME ExitGAMESTOP CORP NEWput$0-47,700
-100.0%
-0.16%
RYAM ExitRAYONIER ADVANCED MATLS INC$0-178,651
-100.0%
-0.18%
ExitCASTLE A M & COnote 7.000/1$0-3,623,000
-100.0%
-0.18%
RYI ExitRYERSON HLDG CORP$0-403,226
-100.0%
-0.23%
USAK ExitUSA TRUCK INC$0-154,996
-100.0%
-0.30%
REXI ExitRESOURCE AMERICA INCcl a$0-691,032
-100.0%
-0.41%
BCOV ExitBRIGHTCOVE INC$0-641,972
-100.0%
-0.41%
FNTCU ExitFINTECH ACQUISITION CORP*unit 99/99/9999$0-450,000
-100.0%
-0.50%
SIR ExitSELECT INCOME REIT$0-365,457
-100.0%
-0.87%
CRWN ExitCROWN MEDIA HLDGS INCcl a$0-2,275,217
-100.0%
-1.19%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2016-08-15
Signatures

The EDGAR filing(s) were signed by:

About Nantahala Capital Management

Nantahala Capital Management is a hedge fund that was founded in 2004 by Wil Harkey. The firm is headquartered in Connecticut and has additional offices in New York and North Carolina. Nantahala Capital Management primarily invests in the technology, healthcare, and consumer sectors. The firm has a long-term investment approach and seeks to identify undervalued companies with strong growth potential.

Wil Harkey serves as the CEO and Chief Investment Officer of Nantahala Capital Management. He has over 20 years of experience in the finance industry and previously worked at Goldman Sachs and Maverick Capital. In addition to Harkey, the firm's leadership team includes COO and General Counsel, David Kozak, and CFO, Michael Kozak.

Nantahala Capital Management has a strong track record of generating positive returns for its investors. The firm's flagship fund, the Nantahala Fund, has delivered an annualized return of over 20% since its inception in 2006. The firm's success can be attributed to its disciplined investment approach and focus on long-term value creation.

Overall, Nantahala Capital Management is a well-respected hedge fund with a talented leadership team and a strong track record of performance. However, as with any investment, it is important for investors to conduct their own due diligence and carefully consider the risks before investing in the firm's funds.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ISHARES TR42Q3 202327.2%
CODEXIS INC42Q3 20233.9%
PATHWARD FINANCIAL INC35Q3 20236.3%
SCIENTIFIC GAMES CORP34Q3 20225.3%
DOVER MOTORSPORTS INC34Q3 20210.5%
GOLDEN ENTMT INC33Q3 20232.1%
QAD INC32Q3 20212.6%
SCIENTIFIC GAMES CORP31Q4 20217.7%
DOLBY LABORATORIES INC31Q4 20205.6%
LINCOLN EDL SVCS CORP31Q4 20210.7%

View Nantahala Capital Management's complete holdings history.

Latest significant ownerships (13-D/G)
Nantahala Capital Management Q2 2016 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
AYTU BIOPHARMA, INCJune 16, 20231,086,81219.7%
Acer Therapeutics Inc.February 14, 20231,226,1917.5%
Aeglea BioTherapeutics, Inc.February 14, 20234,611,3027.5%
AKUMIN INC.February 14, 20232,206,9602.5%
ALTA EQUIPMENT GROUP INC.February 14, 20231,188,9853.7%
Apollo Endosurgery, Inc.February 14, 20234,056,6279.9%
Autolus Therapeutics plcFebruary 14, 20237,782,0184.7%
Bioventus Inc.February 14, 20233,168,5745.1%
CATALYST BIOSCIENCES, INC.February 14, 2023438,0551.4%
Drive Shack Inc.February 14, 20236,500,0007.0%

View Nantahala Capital Management's complete significant-ownership history.

Latest filings
TypeFiled
42024-03-21
42024-03-15
SC 13G2024-03-11
13F-HR/A2024-02-15
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14

View Nantahala Capital Management's complete filings history.

Compare quarters

Export Nantahala Capital Management's holdings